CXCL10 and tuberculosis: Moreover, a user-friendly quantitative lateral flow assay for detection of IP-10 from antigen stimulated blood in TB patients has shown promising results31,32, indicating that IP-10 based assays, eventually combined with other biomarkers, have the potential to be developed into simple point-of-care (POC) tests.